drugset / Trial / NCT02224313

Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women

NCT02224313

Phase 3 Completed 20 enrolled Intira Sriprasert TherapeuticsMD · collab
Non-randomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to compare the vaginal health between premenopausal and postmenopausal women before and after using oral "estradiol" for 14 days then "estradiol" and "progesterone" for 14 days.

Timeline

Start
2015-12
Primary completion
2018-08
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 1 mg Oral
Subject Progesterone Other / unclassified 100 mg Oral

Indications

No indication recorded.